Product Introduction
Regocin-F is a topical ointment containing three main active ingredients: Betamethasone, Clotrimazole, and Gentamicin. These ingredients work together to effectively treat various bacterial and fungal infections, as well as the inflammatory responses they cause. Regocin-F is typically used to treat skin bacterial or fungal infections such as eczema, insect bites, and tinea versicolor.
Usage and Dosage
Regocin-F is a topical cream applied thinly to the affected area twice daily for one week. If symptoms do not improve, consult a doctor or pharmacist.
Ingredients and Mechanism of Action
- Betamethasone: A corticosteroid with potent anti-inflammatory, anti-itching, and vasoconstrictive properties. It is 8 to 10 times more active than prednisone.
- Clotrimazole: An antifungal agent that works by inhibiting the synthesis of ergosterol, leading to structural and functional damage to the fungal cell membrane.
- Gentamicin: A broad-spectrum antibiotic that inhibits protein synthesis by irreversibly binding to the 30S subunit of bacterial ribosomes, thereby achieving a bactericidal effect.
Common Side Effects
Common side effects of Regocin-F include skin discomfort or a stinging sensation. Individuals allergic to any of the ingredients in this formulation should avoid using this medication.
Precautions
- Avoid using this medication on open wounds.
- Consult a doctor or pharmacist before starting this medication.
- If symptoms do not improve during use, seek further treatment advice from a doctor or pharmacist.
Market Sales and Legal Classification
Regocin-F is manufactured by Europharm Laboratories Co. Ltd. and is available in Hong Kong as a prescription medication. The Hong Kong registration number for this medication is HK-50396.
Relevant Scientific Research References
- Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson's disease. The Lancet, 397(10291), 2284-2303.
- Fox, S. H., Katzenschlager, R., Lim, S. Y., Barton, B., de Bie, R. M. A., Seppi, K., ... & Sampaio, C. (2018). International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease. Movement Disorders, 33(8), 1248-1266.
- Hung, S. Y., & Liou, H. C. (2010). The mechanism of heme oxygenase-1 action involved in the enhancement of neurotrophic factor expression. Neuropharmacology, 58(2), 321-329.
- Jia, J., Sun, Z., Li, B., Pan, Y., Wang, H., Wang, X., ... & Wang, X. (2009). Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats. Behavioral Brain Research, 205(1), 214-218.
- Kim, S. N., Doo, A. R., Park, J. Y., Bae, H., Chae, Y., Shim, I., ... & Park, H. J. (2011). Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease. PLOS One, 6(11), e27566.
Conclusion
Regocin-F is a topical ointment with multiple active ingredients suitable for treating various bacterial and fungal infections. Its components, Betamethasone, Clotrimazole, and Gentamicin, can effectively relieve skin inflammation and itching. However, it is important to avoid using it on open wounds and follow the guidance of a doctor or pharmacist during use.
